Skip to product information
1 of 1

Zoetis

FluSure XP/RespiSure-One/ER Bac Plus

FluSure XP/RespiSure-One/ER Bac Plus

Regular price $92.99 USD
Regular price Sale price $92.99 USD
Sale Sold out
Size: 50 Dose
For vaccination of healthy swine 3 weeks or older, including pregnant sows and gilts, as an aid in preventing respiratory disease caused by Swine Influenza virus subtypes H1N1, H1N2 and H3N2, and Mycoplasma hyopneumoniae for a period of 25 weeks, and Erysipelas caused by E. rhusiopathiae for a period of 20 weeks. A 10-week duration of immunity following vaccination has been demonstrated against SIV H3N2.

Dosage: 2 ml IM, revaccinate with FluSure XP/ER Bac Plus in 3 weeks. Vaccinate young pigs after maternally derived antibodies have declined.
Revaccinate semi-annually. 21-day slaughter withdrawal.

Manufacturer and/or Label Information

ZOETIS INC.
333 PORTAGE STREET, KALAMAZOO, MI, 49007
Telephone: 269-359-4414
Customer Service: 888-963-8471
Website: www.zoetis.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.
FluSure XP®/RespiSure-ONE®/ER Bac Plus®

Zoetis

Swine Influenza Vaccine, H1N1 & H1N2 & H3N2

Killed Virus

Erysipelothrix Rhusiopathiae-Mycoplasma Hyopneumoniae Bacterin

For use in swine only

For veterinary use only

H1N1 GAMMA

H1N2 DELTA-1

NOW WITH H3N2 CLUSTER-IV-A

NOW WITH H3N2 CLUSTER-IV-B

This product has been shown to be effective for the vaccination of healthy swine, including pregnant sows and gilts, 3 weeks of age or older against respiratory disease caused by swine influenza A virus (SIV) types H1N1, H1N2, and H3N2, and Mycoplasma hyopneumoniae; and erysipelas caused by Erysipelothrix rhusiopathiae. A duration of immunity of at least 10 weeks has been demonstrated against SIV type H3N2, at least 25 weeks against M. hyopneumoniae, and at least 20 weeks against E. rhusiopathiae. Duration of immunity of the remaining fractions has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

This product contains the following influenza A virus isolates: A/Swine/Iowa/110600/2000 (H1N1); A/Swine/Oklahoma/0726H/2008 (H1N2); A/Swine/North Carolina/ 394/2012 (H3N2); and A/Swine/Minnesota/872/2012 (H3N2).

Directions: Shake diluent before use. Aseptically rehydrate the freeze-dried vaccine with the liquid bacterin provided, shake well, and administer 2 mL intramuscularly. Administer a single 2-mL dose to healthy swine, followed by a single dose of FluSure XP/ER Bac Plus approximately 3 weeks later. In young pigs, vaccinate after maternally derived antibodies to SIV and E. rhusiopathiae have declined. For advice on revaccination, contact your veterinarian or the manufacturer.

Precautions: Store at 2°-8°C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Contains gentamicin and thimerosal as preservatives. Do not mix with other products, except as specified above. In case of human exposure, contact a physician.

Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471.

VLN 190/PCN 4994.2D

Zoetis Inc., Kalamazoo, MI 49007, USA

50-dose vial of vaccine, rehydrate to 100 mL

100-mL vial of liquid bacterin for use as diluent

40038066

CPN: 3690252.6
COLORADO SERUM COMPANY4950 YORK STREET, P.O. BOX 16428, DENVER, CO, 80216-0428Telephone: 303-295-7527Order Desk: 800-525-2065Fax: 303-295-1923Website: www.colorado-serum.comEmail: colorado-serum@colorado-serum.comTHIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

TETANUS TOXOID-CONCENTRATED

Colorado Serum

Adjuvanted

GENERAL INFORMATION: This product has been shown to be effective for the vaccination of healthy horses, cattle, sheep, goats, and swine against tetanus. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity is unknown. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Safety in pregnant animals is unknown.

Tetanus Toxoid is prepared by detoxifying tetanus toxin in such a manner as to allow the antigenic properties to remain intact. Product is purified, concentrated and adjuvanted to provide a low dose effective immunizing agent.

Each serial is tested for purity, safety, and potency in accordance with USDA requirements.

Tetanus is caused by a neurotoxin produced by growth of Clostridium tetani, an anaerobic (lives without air) micro-organism, in necrotic tissue. Affected animals become stiff, have difficulty swallowing, and have an increased pulse rate. Breathing is labored. Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw.

Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw. Thus, the term “lockjaw” is often used. Legs and tail are often stiff with abdominal muscles contracted. Tetanus stricken animals may be unusually sensitive to light and heat. Temperature of the animal generally remains normal, elevating only shortly before death.

Protective antibody levels usually occur about two weeks after the second injection of the primary immunization series. In contrast, administration of Tetanus Antitoxin is recommended for immediate, emergency, passive treatment of exposed animals with unknown vaccination history or with signs of tetanus infection.

DIRECTIONS: Do not vaccinate within 21 days before slaughter. Store at 2-8° C. Do not freeze. Do not mix with other products. Shake well before use. Use entire contents when first opened.

PRECAUTIONS: A transitory local reaction may occur at injection site. Anaphylactoid reaction may occur following administration of products of this nature. If noted, administer adrenalin or equivalent. In case of human exposure, consult a physician.

DOSAGE & ADMINISTRATION: For primary immunization, two doses should be administered subcutaneously or intramuscularly approximately 30 days apart. Use intramuscularly for horses as local reactions are more likely to occur if injected subcutaneously.

Horses: 1 ml IM

Cattle: 1 ml SC or IM

Sheep, Goats, Swine: 0.5 ml SC or IM

Historically, annual single dose revaccination has been recommended. Contact veterinarian for advice.

OTHER INFORMATION: Contains thimerosal and formalin as preservatives. Tetanus Toxoid Concentrate is available in single dose size packaged 10 vials to the carton, and in 10 dose vials.

THE PEAK OF QUALITY SINCE 1923

VLN: 188 / PCN: 8601.00

COLORADO SERUM COMPANY, 4950 York Street, Denver, Colorado 80216

303-295-752

www.colorado-serum.com

Contact us for information on other Colorado Serum Company products. Fine Veterinary Products since 1923.

FOR VETERINARY USE ONLY

 

 

Order #

10 - 1 ml vials

10 - 1 dose vials

11411

10 ml

10 doses

11415

CPN: 1101033.3

Dimensions

Care information

View full details